Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 74144

4 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
May 12, 2016
Product types
Drug
Classifications
Class I
Statuses
Terminated
Recalling firm wording
SOS Telecom Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

4 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 4

Tiger-X, 1200 mg, 1 capsule per pack , 24 single packs per box

D-0101-2017
Recall number
D-0101-2017
Initiated
May 12, 2016
Classification
Class I
Status
Terminated
Recalling firm
SOS Telecom Inc.
Quantity
N/A

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements

Code information

Lot No: 9236999; Best use by: 12/16/2016

Distribution pattern

NY

drug · product 2 of 4

Ninja-X, 4200 mg, 1 capsule per pack, 24 single packs per box.

D-0102-2017
Recall number
D-0102-2017
Initiated
May 12, 2016
Classification
Class I
Status
Terminated
Recalling firm
SOS Telecom Inc.
Quantity
N/A

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements

Code information

Lot: 7920888; Best Use by: 6/31/2018

Distribution pattern

NY

drug · product 3 of 4

Ginseng Power-X , 1800 mg, 1 capsule per pack , 24 single packs per box.

D-0103-2017
Recall number
D-0103-2017
Initiated
May 12, 2016
Classification
Class I
Status
Terminated
Recalling firm
SOS Telecom Inc.
Quantity
N/A

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements

Code information

Lot: 7788965; Best use by: 10/15/2018

Distribution pattern

NY

drug · product 4 of 4

Super Samurai-X , 1000 mg, 1 capsule per pack , 24 single packs per box.

D-0104-2017
Recall number
D-0104-2017
Initiated
May 12, 2016
Classification
Class I
Status
Terminated
Recalling firm
SOS Telecom Inc.
Quantity
N/A

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements

Code information

Lot: 7920499; Best use by: 10/15/2016

Distribution pattern

NY

Field note

Send feedback

We'll only use this to respond to your feedback.